Boehringer Ingelheim, Germany

Boehringer Ingelheim is a family-owned, globally acting, research-driven pharmaceutical company. Focusing on diseases for which no satisfactory treatment options exist to date, Boehringer Ingelheim’s goal is to improve the health and quality of life of patients.
The company has different fully equipped research sites across the globe, the largest one located in Biberach, Germany.
Within the field of cardio-metabolic diseases research, the focus areas are non-alcoholic steato-hepatitis (NASH) / fibrosis, retinal diseases as well as obesity for which innovative therapeutic principles are being identified and developed.
For this purpose, Boehringer Ingelheim is strongly committed to complex human cellular models that have the potential to recapitulate key aspects of the disease pathology and thereby can help with the progression of novel therapeutic molecules.

Role in the project: Hosting secondments